fda warning letters glp-1 october 2025 news Drug Recalls and Warnings: Illegal Sales and Misleading Marketing by Novo Nordisk and Eli Lilly FDA warns telehealth companies over

While the side effects are usually temporary and manageable, be aware of any more serious reactions, including dizziness, abdominal pain, or signs of low blood sugar (if youre also taking diabetes medications)

[DOI] [PubMed] [Google Scholar] 64.Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition

Tirzepatide: A Dual-Action Star SURMOUNT-1 Trial People on tirzepatide lost up to 20.9% of their body weight after 72 weeks

Focus on compliance, value, and scalability to ensure a successful product launch

TRIUMPH-4 did show improvements in several cardiovascular risk markers: reductions in non-HDL cholesterol, triglycerides, high-sensitivity C-reactive protein (hsCRP), and systolic blood pressure

However, these benefits may never come to fruition if GLP-1 RAs induce dietary modifications that create maladaptive gut microbiome shifts, especially over the long term